Symptoms, effects on quality of life, judgement and expectations of treatment in active ankylosing spondylitis: The patient's View;Aktiver morbus bechterew: Symptomatik, einschränkung der lebensqualität, therapiebeurteilung und therapieerwartung aus sicht des patienten

Rehabilitation

Volumn 40, Issue 5, 2001, Pages 275-279

  Falkenbach, A ^a   Curda, B ^a  

^a Forschungsinstitut Gastein und Krankenanstalt Gasteiner Heilstollen   (Germany)

Author keywords

Activity; Ankylosing spondylitis; Interview; Rehabilitation; Symptoms; Therapy

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DYSPNEA; EXPECTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE FATIGUE; MUSCLE TONE; PATIENT SATISFACTION; QUALITY OF LIFE; REHABILITATION MEDICINE; SLEEP;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PATIENT SATISFACTION; QUALITY OF LIFE; SPONDYLITIS, ANKYLOSING;

EID: 0034782046     PISSN: 00343536     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17413     Document Type: Article

References (21)

1. Ankylosing spondylitis: Clinical aspects
2. Epidemiology of ankylosing spondylitis in Rochester, Minnesota 1935-1973
3. Ankylosing spondylitis
4. The individual with ankylosing spondylitis: Defining disease status and the impact of the illness
5. Functional assessment in ankylosing spondylitis: Evaluation of a new self-administered questionnaire and correlation with anthropometric variables
6. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
7. Defining spinal mobility in ankylosing spondylitis (AS): The Bath AS Metrology Index
8. Evaluation of a functional index and an articular index in ankylosing spondylitis
9. A modification of the Health Assessment Questionnaire for the spondyloarthropathies
10. A Dutch version of the Functional Index for ankylosing spondylitis: Development and validation in a long-term study
11. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS, working group
12. Disease assessment indices: Activity, damage and severity
13. Disease activity in ankylosing spondylitis: Selection of a core set of variables and a first set in the development of a disease activity score
14. A new approach to defining disease status in ankylosing spondylitis; The Bath Ankylosing Spondylitis Disease Activity Index
15. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis
16. In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility
17. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
18. Interleukin-6 serum concentration in ankylosing spondylitis: A reliable predictor of disease progression in the subsequent year?
19. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
20. Fatigue in ankylosing spondylitis why is it ignored?
21. Fatigue in ankylosing spondylitis: Its prevalence and relationship to disease activity, sleep, and other factors